美托洛尔-话题@MedSci

#美托洛尔#

16篇内容 | 974人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1337154, encodeId=376a133e154a9, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=酒石酸美托洛尔 VS 琥珀酸美托洛尔，这3点区别要清楚！, objectType=article, longId=732371, objectId=9d09e3237199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d09e3237199, replyNumber=0, likeNumber=58, createdTime=2022-07-15, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d09e3237199, moduleTitle=酒石酸美托洛尔 VS 琥珀酸美托洛尔，这3点区别要清楚！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d09e3237199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337153, encodeId=7593133e153a6, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=美托洛尔、比索洛尔、阿替洛尔…… β 受体阻滞剂全面总结！, objectType=article, longId=293850, objectId=cb88293850dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb88293850dd, replyNumber=0, likeNumber=51, createdTime=2022-01-13, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb88293850dd, moduleTitle=美托洛尔、比索洛尔、阿替洛尔…… β 受体阻滞剂全面总结！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb88293850dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337152, encodeId=7761133e152c9, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=JACC：证据来了——美托洛尔改善肥厚型心肌病患者梗阻症状，并提高生活质量！, objectType=article, longId=292036, objectId=360c2920367c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=360c2920367c, replyNumber=0, likeNumber=50, createdTime=2021-12-18, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=360c2920367c, moduleTitle=JACC：证据来了——美托洛尔改善肥厚型心肌病患者梗阻症状，并提高生活质量！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=360c2920367c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337151, encodeId=e1b5133e15183, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=JAHA：卡维地洛与美托洛尔对伴有和不伴有2型糖尿病的心衰患者长期死亡率影响的比较, objectType=article, longId=217261, objectId=f28c21e26102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f28c21e26102, replyNumber=0, likeNumber=51, createdTime=2021-09-19, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f28c21e26102, moduleTitle=JAHA：卡维地洛与美托洛尔对伴有和不伴有2型糖尿病的心衰患者长期死亡率影响的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f28c21e26102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337150, encodeId=96e6133e150a9, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=第五轮集采上海开标，太凶残了！降幅98%！9分的美托洛尔，3毛的利伐沙班片, objectType=article, longId=213135, objectId=5f7321313531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f7321313531, replyNumber=0, likeNumber=45, createdTime=2021-06-25, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f7321313531, moduleTitle=第五轮集采上海开标，太凶残了！降幅98%！9分的美托洛尔，3毛的利伐沙班片, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f7321313531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337149, encodeId=a349133e1498f, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=NEJM：美托洛尔预防COPD急性加重（BLOCK COPD试验）？, objectType=article, longId=185528, objectId=36a2185528cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36a2185528cb, replyNumber=0, likeNumber=38, createdTime=2020-01-03, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36a2185528cb, moduleTitle=NEJM：美托洛尔预防COPD急性加重（BLOCK COPD试验）？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36a2185528cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337148, encodeId=9a10133e14867, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=NEJM：美托洛尔预防COPD急性加重的疗效分析, objectType=article, longId=184644, objectId=e96318464445, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e96318464445, replyNumber=0, likeNumber=37, createdTime=2019-12-13, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e96318464445, moduleTitle=NEJM：美托洛尔预防COPD急性加重的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e96318464445)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337147, encodeId=be68133e1476f, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=NEJM：美托洛尔不能预防COPD患者加重恶化, objectType=article, longId=181765, objectId=1b55181e6595, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b55181e6595, replyNumber=0, likeNumber=49, createdTime=2019-10-24, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b55181e6595, moduleTitle=NEJM：美托洛尔不能预防COPD患者加重恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b55181e6595)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337146, encodeId=2102133e1466b, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=Sun Pharma在美国推出新型Kapspargo Sprinkle（美托洛尔琥珀酸酯）, objectType=article, longId=146126, objectId=08441461269d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08441461269d, replyNumber=0, likeNumber=35, createdTime=2018-08-09, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08441461269d, moduleTitle=Sun Pharma在美国推出新型Kapspargo Sprinkle（美托洛尔琥珀酸酯）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08441461269d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337145, encodeId=e013133e145a2, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=AHJ：射血分数降低的心衰：卡维地洛与琥珀酸美托洛尔谁更胜一筹？, objectType=article, longId=138277, objectId=5b741382e7d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b741382e7d0, replyNumber=0, likeNumber=41, createdTime=2018-05-18, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b741382e7d0, moduleTitle=AHJ：射血分数降低的心衰：卡维地洛与琥珀酸美托洛尔谁更胜一筹？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b741382e7d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337144, encodeId=60a2133e1445d, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=JACC：普萘洛尔与美托洛尔治疗ICD患者的电风暴比较, objectType=article, longId=136589, objectId=ba3213658957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba3213658957, replyNumber=0, likeNumber=35, createdTime=2018-04-28, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba3213658957, moduleTitle=JACC：普萘洛尔与美托洛尔治疗ICD患者的电风暴比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba3213658957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337143, encodeId=0cc9133e143b2, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=Cardiovasc Ther：伊伐布雷定vs美托洛尔治疗急性下壁心肌梗死疗效如何？, objectType=article, longId=112064, objectId=f53511206466, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f53511206466, replyNumber=0, likeNumber=41, createdTime=2017-09-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f53511206466, moduleTitle=Cardiovasc Ther：伊伐布雷定vs美托洛尔治疗急性下壁心肌梗死疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f53511206466)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337142, encodeId=19bb133e14245, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=美托洛尔的五个用药细节, objectType=article, longId=102979, objectId=fe981029e9a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe981029e9a4, replyNumber=0, likeNumber=40, createdTime=2017-06-24, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe981029e9a4, moduleTitle=美托洛尔的五个用药细节, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe981029e9a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337141, encodeId=0c73133e14163, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=琥珀酸美托洛尔与酒石酸美托洛尔有什么区别？, objectType=article, longId=77078, objectId=65bde7078b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65bde7078b9, replyNumber=0, likeNumber=34, createdTime=2016-09-11, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65bde7078b9, moduleTitle=琥珀酸美托洛尔与酒石酸美托洛尔有什么区别？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65bde7078b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337140, encodeId=4be0133e14027, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=ASH 2014：与氨氯地平的降压药组合奈必洛尔优于美托洛尔, objectType=article, longId=35069, objectId=206635069db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=206635069db, replyNumber=0, likeNumber=37, createdTime=2014-05-23, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=206635069db, moduleTitle=ASH 2014：与氨氯地平的降压药组合奈必洛尔优于美托洛尔, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=206635069db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337139, encodeId=bb0b133e139db, content=<a href='/topic/show?id=428fe9954c0' target=_blank style='color:#2F92EE;'>#美托洛尔#</a>, objectTitle=ACC2011:在高血压中美托洛尔琥珀酸而不是奈比洛尔升高非对称性精氨酸的水平, objectType=article, longId=2583, objectId=6334258395, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6334258395, replyNumber=0, likeNumber=54, createdTime=2011-05-09, rootId=0, userName=ms3892185887221420, userId=edaf2500125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6334258395, moduleTitle=ACC2011:在高血压中美托洛尔琥珀酸而不是奈比洛尔升高非对称性精氨酸的水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6334258395)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

美托洛尔

2020-05-29

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

酒石酸美托洛尔 VS 琥珀酸美托洛尔，这3点区别要清楚！

2022-07-15

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

美托洛尔、比索洛尔、阿替洛尔…… β 受体阻滞剂全面总结！

2022-01-13

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

JACC：证据来了——美托洛尔改善肥厚型心肌病患者梗阻症状，并提高生活质量！

2021-12-18

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

JAHA：卡维地洛与美托洛尔对伴有和不伴有2型糖尿病的心衰患者长期死亡率影响的比较

2021-09-19

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

第五轮集采上海开标，太凶残了！降幅98%！9分的美托洛尔，3毛的利伐沙班片

2021-06-25

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

NEJM：美托洛尔预防COPD急性加重（BLOCK COPD试验）？

2020-01-03

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

NEJM：美托洛尔预防COPD急性加重的疗效分析

2019-12-13

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

NEJM：美托洛尔不能预防COPD患者加重恶化

2019-10-24

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

Sun Pharma在美国推出新型Kapspargo Sprinkle（美托洛尔琥珀酸酯）

2018-08-09

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

AHJ：射血分数降低的心衰：卡维地洛与琥珀酸美托洛尔谁更胜一筹？

2018-05-18

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

JACC：普萘洛尔与美托洛尔治疗ICD患者的电风暴比较

2018-04-28

zhouqu_8 (审核中...)

前往app查看评论内容

#美托洛尔#

Cardiovasc Ther：伊伐布雷定vs美托洛尔治疗急性下壁心肌梗死疗效如何？

2017-09-07

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

美托洛尔的五个用药细节

2017-06-24

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

琥珀酸美托洛尔与酒石酸美托洛尔有什么区别？

2016-09-11

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

ASH 2014：与氨氯地平的降压药组合奈必洛尔优于美托洛尔

2014-05-23

ms3892185887221420 (审核中...)

前往app查看评论内容

#美托洛尔#

ACC2011:在高血压中美托洛尔琥珀酸而不是奈比洛尔升高非对称性精氨酸的水平

2011-05-09

科室
- - 订阅+
  - 更多科室
工具
服务